Trials / Completed
CompletedNCT00378378
Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)
Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 127 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of Nasonex® (Mometasone Furoate Nasal Spray(MFNS)) in the treatment of nasal polyps in pediatric subjects between the ages of 6 and less than 18 years old. Safety will be the primary focus of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mometasone Furoate Nasal Spray (MFNS) | 100 mcg nasal spray |
| DRUG | Placebo nasal spray | One spray of placebo nasal spray in each nostril once daily for 4 months. |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2006-09-20
- Last updated
- 2024-05-20
- Results posted
- 2010-07-20
Source: ClinicalTrials.gov record NCT00378378. Inclusion in this directory is not an endorsement.